native_samples You've been misinformed. We have pre launch studies with 40k+ participants showing no meaningful risk. And post launch when there were exceedingly rare ("This adverse event is rare, occurring at a rate of about 7 per 1 million vaccinated women between 18 and 49 years old. For women 50 years and older and men of all ages, this adverse event is even more rare.") and not unexpected clotting issues vaccine administration was paused so the issue could be analyzed more thoroughly and quantified specifying to defeat this kind of FUD. "As to safety The Pfizer trial reported serious adverse reactions in 0.6% of vaccine recipients and 0.5% of placebo recipients." https://www.sciencemediacentre.org/expert-reaction-to-phase-... https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/sa... https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer...